Earnings History Data for Sema4 Holdings Corp. (SMFR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Sema4 Holdings Corp.

Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Sema4 Holdings Corp, formerly known as CM Life Sciences, is based in STAMFORD, Conn.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2022	PM	Before the open (Nov 14)	SMFR	Sema4 Holdings Corp.	356.05	-0.20	-0.19	-0.43	Sema4 reports Q3 earnings beat; reaffirms FY22 and 2H guidance [11/14/2022 8:41 AM]	0.8974	-0.12 (-12.02%)	1.02	0.0 (0.00%)	0.80 - 8.14	3,134,386	770,000	26,361
Sema4 reports Q3 earnings beat; reaffirms FY22 and 2H guidance [11/14/2022 8:41 AM] Sema4 Reports Third Quarter 2022 Financial Results and New Strategic Direction [Nov-14-22 08:02AM]
15-08-2022	AH	4:05 PM ET (Aug 15)	SMFR	Sema4 Holdings Corp.	611.14	-0.21	-0.19	0.00	Sema4 Q2 GAAP EPS of -$0.25, revenue of $36.2M, FY22 revenue guidance below consensus [8/15/2022 4:56 PM]	1.59	-0.80 (-33.54%)	1.82	-0.58 (-24.17%)	1.11 - 11.61	5,938,566	1,870,000	192,367
Sema4 Q2 GAAP EPS of -$0.25, revenue of $36.2M, FY22 revenue guidance below consensus [8/15/2022 4:56 PM] Dan Loeb's Third Point takes new stakes in Colgate, Antero, exits S&P Global [8/15/2022 5:37 PM] Sema4 downgraded at Jefferies citing Q2 miss and guidance cut [8/16/2022 10:58 AM] Sema4 Announces Continued Restructuring, Business Highlights, and Reports Second Quarter 2022 Financial Results [Aug-15-22 04:05PM] Sema4 Announces Changes to its Research & Development Leadership [Aug-15-22 04:05PM]
12-05-2022	AH	4:05 PM ET (May 12)	SMFR	Sema4 Holdings Corp.	671.50	-0.26	-0.28	0.00	Sema4 GAAP EPS of -$0.31 beats by $0.05, revenue of $53.9M beats by $3.73M [5/12/2022 4:44 PM]	2.06	0.35 (20.06%)	1.76	0.04 (2.33%)	1.49 - 15.21	2,601,001	2,840,000	3,511
Sema4 GAAP EPS of -$0.31 beats by $0.05, revenue of $53.9M beats by $3.73M [5/12/2022 4:44 PM] Sema4 Reports First Quarter 2022 Financial Results and Business Highlights [May-12-22 04:05PM]
14-03-2022	AH	4:00 PM ET (Mar 14)	SMFR	Sema4 Holdings Corp.	732.59	-0.17	-0.22	0.00	Sema4 GAAP EPS of -$0.17, revenue of $57.8M [3/14/2022 4:11 PM]	2.65	0.0 (-0.05%)	2.73	0.08 (3.02%)	2.60 - 18.46	1,443,125	1,745,565	15,739
Sema4 GAAP EPS of -$0.17, revenue of $57.8M [3/14/2022 4:11 PM] Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights [Mar-14-22 04:05PM]
15-11-2021	AH	After the close (Nov 15)	SMFR	Sema4 Holdings Corp.	1,900	-0.43	-0.16	0.00	Sema4 reports Q3 results [11/15/2021 5:21 PM]	7.29	-0.53 (-6.78%)	7.84	0.02 (0.26%)	6.75 - 27.18	2,079,183	990,000	8,794
Sema4 reports Q3 results [11/15/2021 5:21 PM] Sema4 Reports Third Quarter 2021 Financial Results and Business Highlights [Nov-15-21 04:01PM]
16-08-2021	AH	After the close (Aug 16)	SMFR	Sema4 Holdings Corp.	2,800	N/A	0.00	0.00	Sema4 reports Q2 results [8/16/2021 4:33 PM]	9.36	-2.00 (-17.61%)	9.00	-2.36 (-20.77%)	8.85 - 27.18	5,629,661	1,310,000	131,741
Sema4 reports Q2 results [8/16/2021 4:33 PM] Virpax Pharmaceuticals, Sesen Bio leads healthcare gainers; Qualigen Therapeutics, Sema4 among major losers [8/17/2021 11:03 AM] Sema4 shares slide 16% on wider Q2 net loss, revenue target update [8/17/2021 11:21 AM] Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights [Aug-16-21 04:05PM]